Atria Investments’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-11,569
Closed -$222K 2079
2025
Q1
$222K Buy
11,569
+1,468
+15% +$43K ﹤0.01% 1773
2024
Q4
$364K Sell
10,101
-855
-8% -$28.9K ﹤0.01% 1488
2024
Q3
$465K Buy
10,956
+280
+3% +$11.9K 0.01% 1368
2024
Q2
$430K Buy
+10,676
New +$445K 0.01% 1379

Other funds holding TNDM

Atria Investments's TNDM Position: Q2 2025 in Review

Atria Investments sold out of Tandem Diabetes Care (TNDM) in Q2 2025, closing a stake of 11,569 shares — an estimated $222K sold.

Atria Investments first reported a position in TNDM in Q2 2024 and held it in 4 quarters. The position peaked at $465K in Q3 2024. 270 funds tracked by Wall St. Rank hold TNDM as of Q2 2025.

  • Atria Investments reported no remaining Tandem Diabetes Care position as of Q2 2025 after selling out during the quarter.
  • Atria Investments sold 11,569 Tandem Diabetes Care shares in Q2 2025, an estimated $222K.
  • Atria Investments first reported a position in Tandem Diabetes Care in Q2 2024 and held it in 4 quarters.
  • Atria Investments's Tandem Diabetes Care position peaked at $465K in Q3 2024.
  • 270 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2025.

Based on Atria Investments's 13F filing for Q2 2025, filed 4 Aug 2025.